Phosphorylation mechanism and structure of serine-arginine protein kinases

Size: px
Start display at page:

Download "Phosphorylation mechanism and structure of serine-arginine protein kinases"

Transcription

1 REVIEW ARTICLE Phosphorylation mechanism and structure of serine-arginine protein kinases Gourisankar Ghosh 1 and Joseph A. Adams 2 1 Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA 2 Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA Keywords mechanism; protein kinase; splicing; SR protein; structure Correspondence J. A. Adams, Department of Pharmacology, University of California, San Diego, La Jolla, CA , USA Fax: Tel: j2adams@ucsd.edu (Received 7 July 2010, revised 9 November 2010, accepted 10 December 2010) doi: /j x The splicing of mrna requires a group of essential factors known as SR proteins, which participate in the maturation of the spliceosome. These proteins contain one or two RNA recognition motifs and a C-terminal domain rich in Arg-Ser repeats (RS domain). SR proteins are phosphorylated at numerous serines in the RS domain by the SR-specific protein kinase (SRPK) family of protein kinases. RS domain phosphorylation is necessary for entry of SR proteins into the nucleus, and may also play important roles in alternative splicing, mrna export, and other processing events. Although SR proteins are polyphosphorylated in vivo, the mechanism underlying this complex reaction has only been recently elucidated. Human alternative splicing factor [serine arginine-rich splicing factor 1 (SRSF1)], a prototype for the SR protein family, is regiospecifically phosphorylated by SRPK1, a post-translational modification that controls cytoplasmic nuclear localization. SRPK1 binds SRSF1 with unusually high affinity, and rapidly modifies about serines in the N-terminal region of the RS domain (RS1), using a mechanism that incorporates sequential, C-terminal to N-terminal phosphorylation and several processive steps. SRPK1 employs a highly dynamic feeding mechanism for RS domain phosphorylation in which the N-terminal portion of RS1 is initially bound to a docking groove in the large lobe of the kinase domain. Upon subsequent rounds of phosphorylation, this N-terminal segment translocates into the active site, and a b-strand in RNA recognition motif 2 unfolds and occupies the docking groove. These studies indicate that efficient regiospecific phosphorylation of SRSF1 is the result of a contoured binding cavity in SRPK1, a lengthy Arg-Ser repetitive segment in the RS domain, and a highly directional processing mechanism. Introduction The complexity of the human proteome is regulated through the alternative splicing of large precursor mrnas [1]. Although this process plays a significant role in normal cellular development, changes or defects in alternative splicing have also been linked to human disease [1 3]. Splicing reactions occur at the Abbreviations CLK, cdc2-like kinase; kdsrpk1, kinase-dead form of human alternative splicing factor; LysC, lysyl endoproteinase; MAPK, mitogen-activated protein kinase; RRM, RNA recognition motif; RS domain, domain rich in Arg-Ser repeats; RS1, N-terminal region of human alternative splicing factor domain rich in Arg-Ser repeats; RS2, C-terminal region of human alternative splicing factor domain rich in Arg-Ser repeats; SRPK, SR-specific protein kinase; SRSF, serine arginine-rich splicing factor; SRSF1, human alternative splicing factor (serine arginine-rich splicing factor 1). FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 587

2 SRPK structure and mechanism G. Ghosh and J. A. Adams spliceosome, a macromolecular complex composed of five small nuclear ribonucleoproteins (U1, U2, U4, U5, and U6) and over 100 auxiliary proteins [4]. Among these many proteins, one family of splicing factors, known as SR proteins, is essential for controlling numerous aspects of mrna splicing as well as other RNA processing events. SR proteins interact with splicing components (U1-70K and U2AF 35 ) early during spliceosome development, and help to establish the 5 and 3 splice sites [5,6]. Later, they recruit the U4 U6ÆU5 tri-small nuclear ribonucleoprotein [7] and also enhance the second catalytic step in splicing [8]. Splicing is tightly coupled to transcription, and SR proteins have been shown to play a role by binding the C-terminal domain of RNA polymerase II and regulating CDK9 [9]. SR proteins serve roles in many postsplicing events, including mrna export [10,11], translation regulation [12,13], and genomic stability [14,15]. More than a decade ago, it was discovered that two protein kinase families [SR-specific protein kinases (SRPKs) and cdc2-like kinases (CLKs)] phosphorylate SR proteins, altering their cellular distribution and activities [16 18]. In the last several years, great strides have been made in understanding how the SRPKs recognize and phosphorylate the SR proteins. In this review, we will highlight how a highly dynamic and distinct interplay between kinase and substrate is necessary for modification of the SR protein human alternative splicing factor [serine arginine-rich splicing factor 1 (SRSF1)], a prototypical SR protein involved both in constitutive and in alternative splicing [19]. These studies have shown that SRPK1 has an interesting feeding mechanism, whereby multiple contacts in the SR protein are utilized to catalyze a lengthy polyphosphorylation reaction. Structural features of SR proteins SR proteins derive their name from a lengthy ( residue) C-terminal tail rich in Arg-Ser repeats known as the RS domain (Fig. 1). SRSF1 (also known as ASF SF2) represents a typical arrangement for an RS domain, where Arg-Ser repeats are bracketed by smaller repeats and some isolated Arg-Ser pairs. In addition to RS domains, SR proteins also contain one or two N-terminal RNA recognition motifs (RRMs) that modulate SR protein interactions in the spliceosome by binding short mrna sequences (splicing enhancers) [20,21]. Numerous screening procedures have revealed that the observed determinants are somewhat nonspecific, raising the possibility that members of the SR protein family serve redundant functions in mrna splicing [22]. Although, in support of this idea, all SR proteins can complement splicing-deficient S100 cytoplasmic extracts of HeLa cells [20], there are other studies showing that certain SR proteins play tissuespecific roles at various developmental stages [23,24], arguing for a specialized role for some SR proteins. Although there is no X-ray structure for an SR protein in either a phosphorylated or unphosphorylated state, a recent NMR structure shows that one of the RRMs of SRSF1 (RRM2) adopts a typical RNA-binding fold [25]. Sequence analyses suggest that SR proteins may have properties consistent with intrinsically disordered proteins, owing to an RS domain that is expected to be largely unstructured [26]. On the other hand, all SRSF4 316 SRSF6 160 SRSF7 118 SRSF2 105 SRSF5 88 SRSF3 79 SRSF1 50 RS domain RRM domain PRSPSYGRSRSRSRSRSRSRSRSNSRSRSYSPRRSRGSPRYSPRHSRSRSRT-C RS1 SRPK phosphorylation nuclear entry/speckle formation RS2 CLK phosphorylation nuclear dispersion Fig. 1. SR protein domain structure. All traditional SR proteins have one or two N-terminal RRMs and one C-terminal RS domain. The amino acid sequence for the RS domain of the prototype SR protein SRSF1 is displayed. Peptide mapping and cellular analyses indicate that the phosphorylation of two segments in this RS domain (RS1 and RS2) by SRPKs and CLKs control the subcellular distribution. 588 FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works

3 G. Ghosh and J. A. Adams SRPK structure and mechanism atom calculations of an eight dipeptide repeat [(Arg- Ser) 8 ] suggest that the unphosphorylated sequence adopts a helical form, with the arginines pointing out into solution for charge minimization, and a compact, claw-like structure upon phosphorylation [27]. Appreciable helical content has not been detected in CD experiments for SRSF1 or its RS domain in either the phosphorylated or unphosphorylated forms [28], suggesting that if the Arg-Ser repeats possess helical structure, it may not be highly stable in solution. Recent studies have shown that the phosphorylated RS domain is protected from dephosphorylation by the neighboring RRMs, suggesting that the RS domain may not be disordered and could pack onto other domains in the SR protein [29]. Nonetheless, although the RRMs adopt a classic RNA-binding fold, it is still not fully clear how the RS domain folds by itself or in the context of the SR protein, or how phosphorylation modifies the SR protein conformation. SR proteins are phosphorylated by two protein kinase families Early studies showed that SR proteins undergo multiple rounds of phosphorylation and dephosphorylation en route to spliceosome assembly [30 32]. Phosphorylation was shown to occur in the RS domain and alter how the SR protein functions in the spliceosome. For example, the SR proteins SRSF1 and SRSF2 (also known as SC35) interact with the 70-kDa subunit of U1 (U1-70K) and the 35-kDa subunit of U2AF (U2AF 35 ) in a phosphorylation-dependent manner [5,6], establishing the appropriate splice sites. More than a decade ago, it was discovered that the SRPK and CLK families of protein kinases can polyphosphorylate RS domains and alter SR protein cellular distribution and splicing function [16,17,33]. However, the role of RS domain phosphorylation in alternative splicing is not well understood. Although some studies have suggested that the RRMs are the principal driving elements for alternative splicing of some precursor mrnas [34], other studies have shown that the phosphoryl content of the RS domain is important. For example, phosphorylation of SRSF1 controls the alternative splicing of the caspase-9 and Bcl-x genes and induction of a proapoptotic phenotype [35]. Although further investigations are needed to provide a more forceful link between RS domain modification and splicing, it has become abundantly clear that phosphorylation is directly linked to the nuclear entry of SR proteins. It has been shown that phosphorylation of the RS domain leads to enhanced interactions with the nuclear import receptor, transportin SR, and entry of the SR proteins into the nucleus, where they largely reside in speckles [36 38]. Whereas SRPKs play a direct role in nuclear import, the CLK family controls the nuclear distribution of SRSF1 and other SR proteins. Thus, through interactions with two families of protein kinases, the cellular location and, presumably, splicing function of SR proteins can be precisely controlled. Kinetic studies on SRPK1 and SRSF1, together with crystal structures of SRPK1 bound to peptide and protein substrates and the recent structures of CLK1 and CLK3, suggest an elegant mechanism of recognition and phosphorylation by these two kinases, which regulate the biological function of SR proteins in the cell. SRPK1 structure Most of our knowledge regarding SRPKs comes from studies on SRPK1 and the yeast analog, Sky1p. SRPKs contain a well-conserved kinase domain that is bifurcated by a large, nonconserved insert domain (approximately 250 amino acids). The insert domain in SRPKs regulates subcellular localization, as its deletion changes the distribution pattern of the kinase from nuclear cytoplasmic to exclusively nuclear [39]. In addition to this important regulatory domain, SRPKs contain N-terminal and or C-terminal extensions, which are not conserved. Deletion of the insert and N- terminal extension does not inactivate the catalytic activity of SRPK1, suggesting that these elements play auxiliary roles [40]. The X-ray structure for SRPK1 lacking its N-terminus and most of the insert domain reveals the signature bilobal fold found in all eukaryotic protein kinases (Fig. 2A). The small lobe is composed mostly of b-strands, and binds the nucleotide (ADP in the SRPK1 structure). The larger lobe is composed mostly of a-helices, and provides residues important for substrate binding. A short segment of the insert domain connecting the two major kinase lobes is present, and adopts short helical conformations. Like other members of the CMGC group of protein kinases, SRPK1 contains a small insert within the kinase domain known as the mitogen-activated protein kinase (MAPK) insert, which connects helices ag and ah (Fig. 2A). Although the X-ray structure of SRPK1 was solved with a short substrate peptide, this peptide binds unexpectedly outside the active site in a groove generated by the MAPK insert and a loop connecting helices af and ag (Fig. 2A). Later, we will discuss how this docking groove binds SRSF1 and feeds the RS domain into the active site for sequential phosphorylation. X-ray structures of the kinase domains of CLK1 and CLK3 have been reported recently [41], and are FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 589

4 SRPK structure and mechanism G. Ghosh and J. A. Adams Fig. 2. Structural features of SRPK1. (A) Ribbon diagram of SRPK1 in complex with ADP and a short peptide substrate (RRRERSPTR). The peptide binds near the MAPK insert. SRPK1 lacks most of its N-terminus (1 41) and insert domain ( ). (B) Several conserved structural elements and contacts in SRPK1. worth noting here, given their overlapping substrate specificities with the SRPKs. Although the CLK family of protein kinases is capable of widespread RS domain phosphorylation, their structures are distinct from those of the SRPKs in several ways. Most significantly, the CLK enzymes lack a large insert domain dividing the kinase core and, unlike the SRPKs, are autophosphorylated on both serine and tyrosine [42]. The CLK kinases have large N-termini, as do the SRPKs, but, unlike in the SRPKs, these extensions are rich in isolated Arg-Ser dipeptides. Although the CLK family also belongs to the CMGC group of kinases, changes in the sequence of the MAPK insert and positions of helices ag and ah result in the loss of the deep substrate docking groove observed in SRPK1. In addition to the MAPK insert, CLK1 and CLK3 contain another small insert between stands b6 and b9 in the kinase core that interacts with a hydrophobic pocket near the hinge region connecting the kinase lobes. Maintenance of the constitutively active conformation Whereas many protein kinases are highly regulated through diverse mechanisms, SRPK family members are constitutively active and require no post-translational modifications or additional protein subunits for optimal activity. Several key structural elements are essential in the maintenance of this highly active form of SRPK1. In some protein kinases, the activation loop plays a regulatory role by controlling access to the active site, and only adopts an open configuration upon phosphorylation by other protein kinases [43,44]. The activation loop of SRPK1 is comparatively short and, lacking a reversible phosphorylation site, adopts a stable conformation that allows ready access of substrates to the active site (Fig. 2B). Extensive biochemical analyses have shown that the activation loop in SRPK1 is highly malleable [45]. Molecular dynamics simulations have shown that alternative residues can mediate contacts that are lost upon mutation of some residues in the activation segment and maintain the structural integrity of the activation segment. Thus, SRPK1 is resilient to inactivation, and exhibits robust phosphorylation activity. The extensive phosphorylation that SRPK1 must execute for each SR protein is a likely explanation for the evolution of such robust activity. In addition to activation loops, all protein kinases possess a catalytic loop with a conserved aspartic acid that forms a hydrogen bond with the hydroxyl serine tyrosine of the substrate. In the case of SRPK1, the catalytic loop aspartate is ideally poised to abstract the hydroxyl hydrogen from the substrate serine, a necessary step for protein phosphorylation [46]. Several short-range interactions within the small lobe and between the large and small lobes around the active site participate in maintaining the catalytically active conformation. Two conserved interactions in all active protein kinases are also present in SRPK1: an ion pair between an invariant glutamic acid in helix ac and an invariant lysine in strand b3 in the small lobe, and a hydrogen bond between the activation loop and helix ac (Fig. 2B). Regiospecific phosphorylation of the RS domain of SRSF1 Although both the SRPK and CLK families catalyze multisite phosphorylation of SR proteins, the structural data suggest that differences in critical regions 590 FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works

5 G. Ghosh and J. A. Adams SRPK structure and mechanism such as the MAPK insert and N-terminus may impart distinct regiospecificities. To address this issue, the mechanism of phosphorylation of SRSF1 by both enzymes was investigated with MS methods. As shown in Fig. 1, the RS domain of SRSF1 contains many serines throughout, and it is not clear whether these two kinases show preferences for specific residues. The mapping of phosphorylation sites in the RS domain is a vexing problem, owing to the redundancy of the Arg-Ser repeats and difficulties in separating identifying the closely related polybasic fragments in traditional mapping studies. This problem has been circumvented by using a modified form of SRSF1 that contains four Arg fi Lys substitutions in the RS domain. Upon phosphorylation and cleavage with lysyl endoproteinase (LysC), five fragments encompassing the complete RS domain of SRSF1 could be identified by MALDI-TOF MS [47]. These studies detected about eight phosphoserines in the N-terminal portion of the RS domain. To further define the phosphorylation segment in SRSF1, a wide series of truncation derivatives were made, and their phosphoryl contents were assessed by MS [48]. These studies showed definitively that SRPK1 is a regiospecific protein kinase, preferring to phosphorylate up to 12 serines in the N-terminal region of the RS domain of SRSF1 (RS1) (Fig. 1). Single turnover kinetic studies have shown that RS1 is phosphorylated very efficiently within 1 2 min. In comparison, CLK1 does not show this regiospecificity, and instead can phosphorylate all 20 serines in the RS domain of SRSF1 [47]. Furthermore, CLK1 appears to be able to completely phosphorylate the RS domain of SRSF1 even if RS1 is prephosphorylated by SRPK1. This sequential phosphorylation of RS1 (by SRPK1) and the C-terminal region of the RS domain of SRSF1 (RS2) (by CLK1) segments is biologically relevant, as it has been demonstrated that SRSF1 lacking RS2 translocates to the nucleus but is neither additionally phosphorylated nor dispersed in the nucleus by CLK1 [40]. These studies provide a model in which SRPK1 phosphorylates RS1, leading to translocation of SRSF1 from the cytoplasm to nuclear speckles, whereas CLK1 phosphorylates RS2, leading to broad nuclear dispersion of the SR protein. Mechanism of RS domain phosphorylation Although it is not uncommon for protein kinases to exhibit somewhat relaxed substrate specificities and phosphorylate more than one site in their protein target [49 52], SRPK1 possesses the distinct ability to efficiently insert numerous phosphates in close proximity in RS domains. In general, protein kinases recognize local charges flanking the site of phosphorylation [53]. Random library searches have shown that SRPK prefers to phosphorylate serine, but not threonine, that is next to arginines [54]. These studies were performed with a biased peptide library (arginine fixed in the P-3 position), that contained a single serine for modification. In contrast, SRPKs phosphorylate many consecutive serines in a richly electropositive substrate. To accomplish this task, SRPK would need to maneuver deftly through a substrate whose charge is dramatically changing after each round of phosphorylation. The question that this raises is whether these splicing kinases must re-engage the RS domain after each phosphorylation reaction through a sequence of dissociation association steps (distributive phosphorylation), or whether the RS domain can stay attached during subsequent rounds of phosphorylation, simply translating through the active site (processive phosphorylation) (Fig. 3A). There are examples of protein kinases that catalyze multisite phosphorylation using either mechanism and sometimes a combination of both. For example, the nonreceptor protein tyrosine kinase Src phosphorylates up to 15 tyrosines in the protein Cas by a processive mechanism [49,50]. In contrast, the dual specific protein kinase MEK activates MAPK through a two-site phosphorylation mechanism that is fully distributive [52,55]. Finally, the yeast cyclin CDK complex from budding yeast (Pho80 Pho85) appears to phosphorylate five serines in the transcription factor Pho4, by a semiprocessive mechanism [56]. The question of how a splicing kinase modifies an SR protein was originally addressed for SRPK1 and its substrate SRSF1, with a start-trap protocol [57]. In this experiment, a peptide inhibitor or a kinase-dead form of SRPK1 (kdsrpk1) is added at the start of the reaction to a preformed enzyme substrate complex in single turnover experiments (i.e. [SRPK1] > [SRSF1]). If the enzyme phosphorylates the RS domain in a distributive manner, then free enzyme and phospho-intermediates of the SR protein will be generated during the reaction that can be trapped by the inhibitor or kdsrpk1 and lead to reaction inhibition [47,48,57,58]. However, if the mechanism is processive, then no free enzyme or phospho-intermediates will be released, and the peptide inhibitor or kdsrpk1 will not be able to stop the reaction. For SRSF1, it was found that SRPK1 phosphorylates, on average, five to eight of the 12 available serines in RS1, using a processive reaction before the enzyme dissociates and continues in a distributive manner. These findings suggest that SRPK1 may use a dual-track mechanism, incorporating both processive and distributive phosphorylation steps (Fig. 3A). Such FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 591

6 SRPK structure and mechanism G. Ghosh and J. A. Adams A Processive phosphorylation SRSF1 SRPK1 Distributive phosphorylation B Directional phosphorylation Fig. 3. Mechanism of SRSF1 phosphorylation by SRPK1. (A) Dual-track mechanism. Start-trap analyses indicate that SRPK1 can phosphorylate up to eight serines in RS1, using a processive mechanism in which the kinase stays attached to the substrate after each round of phosphorylation. The remaining serines in RS1 are modified in a distributive manner, in which the kinase and substrate dissociate after each phosphorylation event. (B) Directional phosphorylation. Mapping studies show that SRPK1 is a directional kinase that initially binds to an initiation box (Ser221 Ser225) in the center of the RS domain, and then moves in an N-terminal direction to maximally phosphorylate RS1. The bold and light arrows indicate that processivity is progressively diminished as SRPK1 translates from the C-terminus to the N-terminus and dissociation becomes favored over forward catalysis. a process is expected to require a stable enzyme substrate complex. Indeed, competition and single turnover analyses indicate that the SRPK1 SRSF1 complex displays unusually high affinity, with a K d between 50 and 100 nm [48,57]. It is likely that this initial high affinity is diminished during subsequent phosphorylation steps, driving a shift from processive to distributive phosphorylation. Accordingly, it has been shown that SRPK1 inefficiently pulls down phosphorylated SRSF1, whereas the unphosphorylated SR protein is robustly pulled down [29,59]. Although this mechanism has been established with the use of SRSF1 that has a rather short RS domain, it remains to be seen whether processivity is a general feature of SRPKs and other SR proteins with much larger RS domains. It is interesting to note that expanding the number of Arg-Ser repeats in SRSF1 leads to enhanced processivity, suggesting that other SR proteins could also be phosphorylated by this mechanism [60]. Directional phosphorylation of RS domains Although SRPK1 can processively phosphorylate several serines in SRSF1, it is not clear how this enzyme attaches phosphates in close succession to a highly charged substrate. DNA polymerase, a classic processive enzyme, adds nucleotide triphosphates in a rigid 5 fi 3 direction, and initiates strictly at a DNA primer [61]. To investigate whether SRPK1 is likewise directional, an engineered protease footprinting technique was employed [58]. In these experiments, a lysine is placed in the center of RS1 of SRSF1, and several additional Lys fi Arg mutations in RRM2 are then inserted. When the resulting substrate is cleaved with LysC, two fragments easily identified on a gel can be obtained that correspond to the N-terminal and C-terminal halves of RS1. This method permits a fast and quantitative method for sorting phosphates placed on either the N-terminal or C-terminal end of RS1. By monitoring of the phosphorylation reaction in single turnover mode and conversion of the substrate into N-terminal and C-terminal fragments with LysC at various reaction stages, it can be shown that SRPK1 phosphorylates RS1 in a C-terminal to N-terminal direction (Fig. 3B). Furthermore, by alteration of the position of the cleavage site in the RS domain, the initiation region at the C-terminal end of RS1 (initiation box) can also be identified. Interestingly, although SRPK1 prefers to start phosphorylation in the initiation box (Ser221 Ser225), mutations in this region do not halt catalysis, indicating that the enzyme possesses the flexibility to move to other sites [58]. This adaptability is likely to be an important feature of SRPK1 function, as the RS domains in other SR proteins are larger and more diverse (Fig. 1). In addition to rapid RS1 phosphorylation, SRPK1 is capable of phosphorylating about three serines in RS2, although about 100-fold more slowly than the serines in RS1 [60]. This overwhelming specificity for RS1 over RS2 is a result 592 FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works

7 G. Ghosh and J. A. Adams SRPK structure and mechanism of SRPK1 s preference for long Arg-Ser repeats, as adding such repeats greatly increases phosphorylation rates in RS2. These findings suggest that SRPK1 scans RS domains in a search for long Arg-Ser stretches, and is clearly capable of docking at additional sites on the basis of local sequence factors. Overall, SRPK1 moves in a well-defined C-terminal to N-terminal direction along the RS domain of SRSF1, and possibly could use a similar mechanism for other SR proteins, although it may be capable of recognizing different and, possibly, multiple initiation boxes. Docking interactions guide multisite phosphorylation Studies on the SRPK1-dependent phosphorylation of SRSF1 have uncovered a remarkable catalytic mechanism, displaying very unusual features. How SRPK1 achieves multisite and directional phosphorylation at the molecular level has recently been revealed through the X-ray structures of SRPK1 bound to either a short peptide substrate (Fig. 2A) or the core region of SRSF1 (RRM2-RS1) (Fig. 4A). These two structures show that SRPK1 possesses a docking region in the large lobe that can accept a portion of the RS domain. This acidic docking groove in the kinase accommodates basic peptides about six to seven residues in length. Mutation of several acidic residues within the docking groove (e.g. Asp564, Glu571, and Asp548) eliminates processive phosphorylation and strong directional preferences within the RS domain [48]. The peptide-bound form of SRPK1 allowed identification of a small segment preceding the RS domain of SRSF1 [(RVKVDGPR( )] as the cognate substrate site that specifically interacts with the docking groove. Mutations of two basic residues in this segment (R191A and K193A) altered the catalytic mechanism, suggesting the importance of this region in SR protein A Fig. 4. Model describing how the RS domain of SRSF1 is threaded into the active site of SRPK1. (A) X-ray structure of the SRPK1 SRSF1 complex. SRSF1 retained the central RRM2 and RS1 segments and lacked RRM1 and RS2. Only a portion of RS1 is well defined in the complex (N -RS1, residues ), and resides in the electronegative docking groove. The dotted circles present the possible path of the segment of SRSF1 disordered in the crystal from N -RS1 to RRM2 and the active site. The surface rendition of CLK1 is shown in the right panel. The dotted circles represent a possible path of the p-rs1 peptide substrate on the kinase. (B) Feeding mechanism. The N-terminal portion of RS1 (N -RS1) initially binds in the docking groove, and the C-terminal portion (initiation box) occupies the active site. Representative Arg-Ser pairs in both segments are represented as green hexagons. The dotted line represents intervening Arg-Ser-rich regions in RS1. In the presence of ATP, RS1 is phosphorylated in a C-terminal to N-terminal direction until residues (b4 of RRM2) occupy the docking groove. Electropositive side chains from the P+2 pocket stabilize the phosphates on RS1. B FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 593

8 SRPK structure and mechanism G. Ghosh and J. A. Adams phosphorylation [40]. However, a subsequent structure that cocrystallized with a truncated form of SRSF1 (RRM2-RS1) revealed that the N-terminal part of the RS domain rather than residues was bound to the docking groove (Fig. 4A). This was surprising, as this RS segment [N -RS1; SYGRSRSRSR( )], binds to a pocket far from the active site (Fig. 4A), but eventually undergoes phosphorylation, as determined by mapping studies [58]. These two kinase structures appeared to offer differing perspectives on which regions outside the RRMs bind in the docking groove. In the RRM2-RS1-bound structure, the docking groove binds an N-terminal segment of RS1 (residues ), whereas in the peptide-bound structure, the docking groove binds sequences that are more N-terminal from N -RS1 (residues ). As prior mapping studies showed that SRPK1 moves along the RS domain in a C-terminal to N-terminal direction (Fig. 3B), it is possible that the structure of the SRPK1 SRSF1 complex changes as a function of phosphorylation, and that the two X-ray structures present two distinct states along the catalytic pathway. This model was tested with mutant forms of SRPK1 and SRSF1 that differentially cross-link as a function of ATP. A cysteine placed in the docking groove of SRPK1 (K604C) cross-links with a cysteine substituted in the segment preceding the RS domain (K193C) only in the presence of ATP. In comparison, a second mutant form of SRSF1 in which a cysteine is inserted in N -RS1 (R204C) cross-links with the docking groove cysteine in the absence of ATP. When considered in light of the directional phosphorylation mechanism, these structural observations can be used to propose a model for substrate phosphorylation in which the Arg-Ser repeat motif constitutes a mobile docking element, where the part of RS1 that is to be phosphorylated (N -RS1; residues ) first serves as a docking sequence placing a C-terminal serine from the initiation box at the active site (Fig. 4B). As each serine undergoes phosphorylation, the docking motif moves by two residue increments towards the N-terminus. Each Arg-Ser tract from the docking groove is sequentially displaced by an N-terminal tract with the originally identified docking motif in the docking groove at the end of the reaction. In essence, the entire RS1 motif is fed through the active site of the kinase until the furthest N-terminal docking motif (residues ) hits the kinase docking groove. Interestingly, residues lie in b-strand 4 of RRM2, so that it must unfold in order to occupy the docking groove, a result supported by CD and mutagenesis experiments [28,62]. Although the C-terminal residues of RS1 are poorly defined in the structure, a single phosphoserine resulting form a small impurity in the cocrystallized nucleotide analog (AMPPNP) was found in the basic P+2 pocket of the kinase (Fig. 4B). Mutations in this pocket (R515A, R518A, and R561A) reduce the rate of phosphate incorporation into the N- Sky1p SRPK1 CLK1 Fig. 5. Surface electrostatic properties of SRPKs and CLKs. Ribbon (top) and electrostatic surface presentations (bottom) for Sky1p, SRPK1 and CLK1 are displayed. All three molecules were crystallized as truncated proteins. The nonconserved N-terminal and spacer domains were deleted in Sky1p and SRPK1. The N-terminal RS domain was deleted in CLK FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works

9 G. Ghosh and J. A. Adams SRPK structure and mechanism terminal portion of RS1 [48], suggesting that the P+2 pocket stabilizes the growing phosphorylated RS domain. Although structural studies on SRPK1 are the most advanced at this time, it is likely that other SR-directed protein kinases will use aspects of the above feeding mechanism. For example, the yeast SRPK, Sky1p, contains a similar charged docking groove to that of SRPK1, which plays a role in the recognition of its cognate substrate Npl3 (Fig. 5). Although Npl3 lacks a classic RS domain, it has a single RS dipeptide at the very C-terminus of its RGG (Arg-Gly-Gly-rich) domain. In vitro studies on Sky1p and Npl3 have shown that the RGG domain contains multiple docking motifs, at least one of which is essential for the interaction of Npl3 with Sky1p [63]. Although Sky1p modifies a rather distinct substrate as compared with SRSF1, it appears that the mobile docking element may be a conserved feature in SR and SR-like proteins and their kinases. In comparison with SRPK1, the X-ray structures of the CLKs revealed no deep groove that would fit a peptide with geometric complementarity (Fig. 4A). Moreover, the corresponding segment that would constitute the SRPK1 docking groove is shallow and dispersed, with both acidic and basic charge patches (Fig. 5). This is comparable to the highly acidic nature of the SRPK1 docking groove. This charge distribution suggests that the hypophosphorylated RS domain with alternate positive and negative charges could interact with CLK with high efficiency as compared with the unphosphorylated RS domain. That is, the product of SRPK1 phosphorylation might be the substrate of CLK. We showed that CLK1 will readily phosphorylate approximately seven serines in RS2 in SRSF1 when it is prephosphorylated in RS1 by SRPK1 [47]. In comparison, SRPK1 can phosphorylate about three serines in RS2 but very inefficiently [60]. The differences between SRPK1 and CLK1 are likely to be rooted in differences in docking elements and charge dispersal (Fig. 5). Whereas SRPK1 catalyzes a very strict, directional mechanism, owing to its electronegative docking groove, CLK1 lacking such a groove randomly phosphorylates the RS domain of SRSF1 [29]. Our understanding of how CLKs modify RS domains will be greatly advanced with the generation of a CLK:RS domain structure and further investigations into its substrate specificity. Conclusion Recent structural and mechanistic studies on the splicing kinase SRPK1 have uncovered a novel phosphorylation mechanism, in which a long section of the substrate s RS domain is fed into the active site through a docking groove in the large lobe (Fig. 4). This mechanism has similarities to polymerase-type chain reactions, where the enzyme binds in a defined region and then proceeds in a directional manner. SRPK1 starts in a narrow initiation box that is defined by the length of a greater binding channel encompassing the docking groove and the active site, a total distance that can accommodate RS1 of the SR protein SRSF1. After initiation, the driving force for the directional reaction is likely to involve a combination of repulsive interactions between the phosphoserines and the electronegative channel, and attractive electrostatic interactions between the phosphoserines and an electropositive P+2 pocket. Whether discrete initiation and extension reactions like those found in SRSF1 are common within the SR protein family awaits further investigations. Although SRSF1 is a prototype for the family and the first to be investigated at a refined mechanistic level, it possesses a relatively small RS domain as compared with others in the SR protein family. It will be interesting to learn how the catalytic principles uncovered for SRSF1 apply to SR proteins with considerably larger RS domains with multiple, lengthy Arg-Ser repeats. Acknowledgements This work was supported by NIH grants to J. A. Adams (GM67969) and G. Ghosh (GM084277). References 1 Tazi J, Bakkour N & Stamm S (2009) Alternative splicing and disease. Biochim Biophys Acta 1792, Venables JP (2006) Unbalanced alternative splicing and its significance in cancer. Bioessays 28, Faustino NA & Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17, Jurica MS & Moore MJ (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 12, Wu JY & Maniatis T (1993) Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75, Kohtz JD, Jamison SF, Will CL, Zuo P, Luhrmann R, Garcia-Blanco MA & Manley JL (1994) Protein protein interactions and 5 -splice-site recognition in mammalian mrna precursors. Nature 368, Roscigno RF & Garcia-Blanco MA (1995) SR proteins escort the U4 U6.U5 tri-snrnp to the spliceosome. RNA 1, FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 595

10 SRPK structure and mechanism G. Ghosh and J. A. Adams 8 Chew SL, Liu HX, Mayeda A & Krainer AR (1999) Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mrna splicing. Proc Natl Acad Sci USA 96, Lin S, Coutinho-Mansfield G, Wang D, Pandit S & Fu XD (2008) The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 15, Huang Y, Yario TA & Steitz JA (2004) A molecular link between SR protein dephosphorylation and mrna export. Proc Natl Acad Sci USA 101, Huang Y & Steitz JA (2001) Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mrna. Mol Cell 7, Sanford JR, Gray NK, Beckmann K & Caceres JF (2004) A novel role for shuttling SR proteins in mrna translation. Genes Dev 18, Sanford JR, Ellis JD, Cazalla D & Caceres JF (2005) Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc Natl Acad Sci USA 102, Labourier E, Rossi F, Gallouzi IE, Allemand E, Divita G & Tazi J (1998) Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2 ASF splicing factor. Nucleic Acids Res 26, Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG, Fu XD & Li X (2007) Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol 27, Gui JF, Lane WS & Fu XD (1994) A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369, Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC & Duncan PI (1996) The Clk Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 15, Duncan PI, Howell BW, Marius RM, Drmanic S, Douville EM & Bell JC (1995) Alternative splicing of STY, a nuclear dual specificity kinase. J Biol Chem 270, Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72, Caceres JF & Krainer AR (1993) Functional analysis of pre-mrna splicing factor SF2 ASF structural domains. EMBO J 12, Zuo P & Manley JL (1994) The human splicing factor ASF SF2 can specifically recognize pre-mrna 5 splice sites. Proc Natl Acad Sci USA 91, Long JC & Caceres JF (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417, Wang HY, Xu X, Ding JH, Bermingham JR Jr & Fu XD (2001) SC35 plays a role in T cell development and alternative splicing of CD45. Mol Cell 7, Xu X, Yang D, Ding JH, Wang W, Chu PH, Dalton ND, Wang HY, Bermingham JR Jr, Ye Z, Liu F et al. (2005) ASF SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation contraction coupling in cardiac muscle. Cell 120, Tintaru AM, Hautbergue GM, Hounslow AM, Hung ML, Lian LY, Craven CJ & Wilson SA (2007) Structural and functional analysis of RNA and TAP binding to SF2 ASF. EMBO Rep 8, Haynes C & Iakoucheva LM (2006) Serine argininerich splicing factors belong to a class of intrinsically disordered proteins. Nucleic Acids Res 34, Hamelberg D, Shen T & McCammon JA (2007) A proposed signaling motif for nuclear import in mrna processing via the formation of arginine claw. Proc Natl Acad Sci USA 104, Ngo JC, Giang K, Chakrabarti S, Ma CT, Huynh N, Hagopian JC, Dorrestein PC, Fu XD, Adams JA & Ghosh G (2008) A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol Cell 29, Ma CT, Ghosh G, Fu XD & Adams JA (2010) Mechanism of dephosphorylation of the SR protein ASF SF2 by protein phosphatase 1. J Mol Biol 403, Xiao SH & Manley JL (1998) Phosphorylation dephosphorylation differentially affects activities of splicing factor ASF SF2. EMBO J 17, Mermoud JE, Cohen PT & Lamond AI (1994) Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 13, Cao W, Jamison SF & Garcia-Blanco MA (1997) Both phosphorylation and dephosphorylation of ASF SF2 are required for pre-mrna splicing in vitro. RNA 3, Colwill K, Feng LL, Yeakley JM, Gish GD, Caceres JF, Pawson T & Fu XD (1996) SRPK1 and Clk Sty protein kinases show distinct substrate specificities for serine arginine-rich splicing factors. J Biol Chem 271, Zhu J & Krainer AR (2000) Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev 14, Massiello A & Chalfant CE (2006) SRp30a (ASF SF2) regulates the alternative splicing of caspase-9 premrna and is required for ceramide-responsiveness. J Lipid Res 47, FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works

11 G. Ghosh and J. A. Adams SRPK structure and mechanism 36 Caceres JF, Misteli T, Screaton GR, Spector DL & Krainer AR (1997) Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138, Kataoka N, Bachorik JL & Dreyfuss G (1999) Transportin-SR, a nuclear import receptor for SR proteins. J Cell Biol 145, Lai MC, Lin RI, Huang SY, Tsai CW & Tarn WY (2000) A human importin-beta family protein, transportin-sr2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 275, Ding JH, Zhong XY, Hagopian JC, Cruz MM, Ghosh G, Feramisco J, Adams JA & Fu XD (2006) Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Mol Biol Cell 17, Ngo JC, Chakrabarti S, Ding JH, Velazquez-Dones A, Nolen B, Aubol BE, Adams JA, Fu XD & Ghosh G (2005) Interplay between SRPK and Clk Sty kinases in phosphorylation of the splicing factor ASF SF2 is regulated by a docking motif in ASF SF2. Mol Cell 20, Bullock AN, Das S, Debreczeni JE, Rellos P, Fedorov O, Niesen FH, Guo K, Papagrigoriou E, Amos AL, Cho S et al. (2009) Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Structure 17, Prasad J & Manley JL (2003) Regulation and substrate specificity of the SR protein kinase Clk Sty. Mol Cell Biol 23, Hubbard SR (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16, Russo AA, Jeffrey PD & Pavletich NP (1996) Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat Struct Biol 3, Ngo JC, Gullingsrud J, Giang K, Yeh MJ, Fu XD, Adams JA, McCammon JA & Ghosh G (2007) SR protein kinase 1 is resilient to inactivation. Structure 15, Valiev M, Kawai R, Adams JA & Weare JH (2003) The role of the putative catalytic base in the phosphoryl transfer reaction in a protein kinase: first-principles calculations. J Am Chem Soc 125, Velazquez-Dones A, Hagopian JC, Ma CT, Zhong XY, Zhou H, Ghosh G, Fu XD & Adams JA (2005) Mass spectrometric and kinetic analysis of ASF SF2 phosphorylation by SRPK1 and Clk Sty. J Biol Chem 280, Hagopian JC, Ma CT, Meade BR, Albuquerque CP, Ngo JC, Ghosh G, Jennings PA, Fu XD & Adams JA (2008) Adaptable molecular interactions guide phosphorylation of the SR protein ASF SF2 by SRPK1. J Mol Biol 382, Patwardhan P, Shen Y, Goldberg GS & Miller WT (2006) Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth. J Biol Chem 281, Pellicena P & Miller WT (2001) Processive phosphorylation of p130cas by Src depends on SH3 polyproline interactions. J Biol Chem 276, Schulze WX, Deng L & Mann M (2005) Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol 1, Burack WR & Sturgill TW (1997) The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36, Adams JA (2001) Kinetic and catalytic mechanisms of protein kinases. Chem Rev 101, Wang HY, Lin W, Dyck JA, Yeakley JM, Songyang Z, Cantley LC & Fu XD (1998) SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mrna splicing factors in mammalian cells. J Cell Biol 140, Ferrell JE Jr & Bhatt RR (1997) Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J Biol Chem 272, Jeffery DA, Springer M, King DS & O Shea EK (2001) Multi-site phosphorylation of Pho4 by the cyclin-cdk Pho80 Pho85 is semi-processive with site preference. J Mol Biol 306, Aubol BE, Chakrabarti S, Ngo J, Shaffer J, Nolen B, Fu XD, Ghosh G & Adams JA (2003) Processive phosphorylation of alternative splicing factor splicing factor 2. Proc Natl Acad Sci USA 100, Ma CT, Velazquez-Dones A, Hagopian JC, Ghosh G, Fu XD & Adams JA (2008) Ordered multi-site phosphorylation of the splicing factor ASF SF2 by SRPK1. J Mol Biol 376, Koizumi J, Okamoto Y, Onogi H, Mayeda A, Krainer AR & Hagiwara M (1999) The subcellular localization of SF2 ASF is regulated by direct interaction with SR protein kinases (SRPKs). J Biol Chem 274, Ma CT, Hagopian JC, Ghosh G, Fu XD & Adams JA (2009) Regiospecific phosphorylation control of the SR protein ASF SF2 by SRPK1. J Mol Biol 390, Kelman Z, Hurwitz J & O Donnell M (1998) Processivity of DNA polymerases: two mechanisms, one goal. Structure 6, Huynh N, Ma CT, Giang N, Hagopian J, Ngo J, Adams J & Ghosh G (2009) Allosteric interactions direct binding and phosphorylation of ASF SF2 by SRPK1. Biochemistry 48, Lukasiewicz R, Nolen B, Adams JA & Ghosh G (2007) The RGG domain of Npl3p recruits Sky1p through docking interactions. J Mol Biol 367, FEBS Journal 278 (2011) Journal compilation ª 2011 FEBS. No claim to original US government works 597

SR Proteins. The SR Protein Family. Advanced article. Brenton R Graveley, University of Connecticut Health Center, Farmington, Connecticut, USA

SR Proteins. The SR Protein Family. Advanced article. Brenton R Graveley, University of Connecticut Health Center, Farmington, Connecticut, USA s s Brenton R Graveley, University of Connecticut Health Center, Farmington, Connecticut, USA Klemens J Hertel, University of California Irvine, Irvine, California, USA Members of the serine/arginine-rich

More information

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct RECAP (1) In eukaryotes, large primary transcripts are processed to smaller, mature mrnas. What was first evidence for this precursorproduct relationship? DNA Observation: Nuclear RNA pool consists of

More information

Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4)

Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4) Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4) Vahagn Stepanyan Department of Biological Sciences, Fordham University Abstract: Alternative splicing is an

More information

Previous Class. Today. Detection of enzymatic intermediates: Protein tyrosine phosphatase mechanism. Protein Kinase Catalytic Properties

Previous Class. Today. Detection of enzymatic intermediates: Protein tyrosine phosphatase mechanism. Protein Kinase Catalytic Properties Previous Class Detection of enzymatic intermediates: Protein tyrosine phosphatase mechanism Today Protein Kinase Catalytic Properties Protein Phosphorylation Phosphorylation: key protein modification

More information

1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics

1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics 1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics to gain mechanistic insight! 4. Return to step 2, as

More information

REGULATED SPLICING AND THE UNSOLVED MYSTERY OF SPLICEOSOME MUTATIONS IN CANCER

REGULATED SPLICING AND THE UNSOLVED MYSTERY OF SPLICEOSOME MUTATIONS IN CANCER REGULATED SPLICING AND THE UNSOLVED MYSTERY OF SPLICEOSOME MUTATIONS IN CANCER RNA Splicing Lecture 3, Biological Regulatory Mechanisms, H. Madhani Dept. of Biochemistry and Biophysics MAJOR MESSAGES Splice

More information

Regulated Cellular Partition of SR Protein Specific Kinases in Mammalian Cells Gilman Drive, La Jolla, CA

Regulated Cellular Partition of SR Protein Specific Kinases in Mammalian Cells Gilman Drive, La Jolla, CA Regulated Cellular Partition of SR Protein Specific Kinases in Mammalian Cells Jian-Hua Ding 1*, Xiang-Yang Zhong 1*, Jonathan C. Hagopian 2, Marissa M. Cruz 1, Gourisankar Ghosh 3, James Feramisco 1,2,

More information

Chapter 11: Enzyme Catalysis

Chapter 11: Enzyme Catalysis Chapter 11: Enzyme Catalysis Matching A) high B) deprotonated C) protonated D) least resistance E) motion F) rate-determining G) leaving group H) short peptides I) amino acid J) low K) coenzymes L) concerted

More information

Effects of Second Messengers

Effects of Second Messengers Effects of Second Messengers Inositol trisphosphate Diacylglycerol Opens Calcium Channels Binding to IP 3 -gated Channel Cooperative binding Activates Protein Kinase C is required Phosphorylation of many

More information

Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia. Dec 14 & 19, 2006 Prof. Erin O Shea Prof. Dan Kahne

Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia. Dec 14 & 19, 2006 Prof. Erin O Shea Prof. Dan Kahne Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia Dec 14 & 19, 2006 Prof. Erin Shea Prof. Dan Kahne 1 Cancer, Kinases and Gleevec: 1. What is CML? a. Blood cell maturation b. Philadelphia Chromosome

More information

Chapter 10. Regulatory Strategy

Chapter 10. Regulatory Strategy Chapter 10 Regulatory Strategy Regulation of enzymatic activity: 1. Allosteric Control. Allosteric proteins have a regulatory site(s) and multiple functional sites Activity of proteins is regulated by

More information

G-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D

G-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D G-Protein Signaling Introduction to intracellular signaling Dr. SARRAY Sameh, Ph.D Cell signaling Cells communicate via extracellular signaling molecules (Hormones, growth factors and neurotransmitters

More information

Statin inhibition of HMG-CoA reductase: a 3-dimensional view

Statin inhibition of HMG-CoA reductase: a 3-dimensional view Atherosclerosis Supplements 4 (2003) 3/8 www.elsevier.com/locate/atherosclerosis Statin inhibition of HMG-CoA reductase: a 3-dimensional view Eva Istvan * Department of Molecular Microbiology, Howard Hughes

More information

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points.

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points. MBB 407/511 Molecular Biology and Biochemistry First Examination - October 1, 2002 Name Social Security Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is

More information

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule.

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule. This exam is worth 90 points. Pages 2- have questions. Page 1 is for your reference only. Honor Code Agreement - Signature: Date: (You agree to not accept or provide assistance to anyone else during this

More information

The Protein Kinase Clk/Sty Directly Modulates SR Protein Activity: Both Hyper- and Hypophosphorylation Inhibit Splicing

The Protein Kinase Clk/Sty Directly Modulates SR Protein Activity: Both Hyper- and Hypophosphorylation Inhibit Splicing MOLECULAR AND CELLULAR BIOLOGY, Oct. 1999, p. 6991 7000 Vol. 19, No. 10 0270-7306/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. The Protein Kinase Clk/Sty Directly

More information

Signal Transduction Cascades

Signal Transduction Cascades Signal Transduction Cascades Contents of this page: Kinases & phosphatases Protein Kinase A (camp-dependent protein kinase) G-protein signal cascade Structure of G-proteins Small GTP-binding proteins,

More information

Cell Signaling part 2

Cell Signaling part 2 15 Cell Signaling part 2 Functions of Cell Surface Receptors Other cell surface receptors are directly linked to intracellular enzymes. The largest family of these is the receptor protein tyrosine kinases,

More information

Enzyme-coupled Receptors. Cell-surface receptors 1. Ion-channel-coupled receptors 2. G-protein-coupled receptors 3. Enzyme-coupled receptors

Enzyme-coupled Receptors. Cell-surface receptors 1. Ion-channel-coupled receptors 2. G-protein-coupled receptors 3. Enzyme-coupled receptors Enzyme-coupled Receptors Cell-surface receptors 1. Ion-channel-coupled receptors 2. G-protein-coupled receptors 3. Enzyme-coupled receptors Cell-surface receptors allow a flow of ions across the plasma

More information

Alan Weiner BIOCHEM 530 Friday, MEB 248 October 23, 2015 RNA structure, the ribosome, structure-based drug design

Alan Weiner BIOCHEM 530 Friday, MEB 248 October 23, 2015 RNA structure, the ribosome, structure-based drug design Alan Weiner BIOCHEM 530 Friday, MEB 248 October 23, 2015 RNA structure, the ribosome, structure-based drug design Crick's "Central Dogma"? DNA makes RNA makes protein Crick's "Central Dogma"? DNA makes

More information

Protein kinases are enzymes that add a phosphate group to proteins according to the. ATP + protein OH > Protein OPO 3 + ADP

Protein kinases are enzymes that add a phosphate group to proteins according to the. ATP + protein OH > Protein OPO 3 + ADP Protein kinase Protein kinases are enzymes that add a phosphate group to proteins according to the following equation: 2 ATP + protein OH > Protein OPO 3 + ADP ATP represents adenosine trisphosphate, ADP

More information

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct RECAP (1) In eukaryotes, large primary transcripts are processed to smaller, mature mrnas. What was first evidence for this precursorproduct relationship? DNA Observation: Nuclear RNA pool consists of

More information

Biol403 MAP kinase signalling

Biol403 MAP kinase signalling Biol403 MAP kinase signalling The mitogen activated protein kinase (MAPK) pathway is a signalling cascade activated by a diverse range of effectors. The cascade regulates many cellular activities including

More information

Proteins are sometimes only produced in one cell type or cell compartment (brain has 15,000 expressed proteins, gut has 2,000).

Proteins are sometimes only produced in one cell type or cell compartment (brain has 15,000 expressed proteins, gut has 2,000). Lecture 2: Principles of Protein Structure: Amino Acids Why study proteins? Proteins underpin every aspect of biological activity and therefore are targets for drug design and medicinal therapy, and in

More information

Receptor mediated Signal Transduction

Receptor mediated Signal Transduction Receptor mediated Signal Transduction G-protein-linked receptors adenylyl cyclase camp PKA Organization of receptor protein-tyrosine kinases From G.M. Cooper, The Cell. A molecular approach, 2004, third

More information

Enzymes Part III: regulation II. Dr. Mamoun Ahram Summer, 2017

Enzymes Part III: regulation II. Dr. Mamoun Ahram Summer, 2017 Enzymes Part III: regulation II Dr. Mamoun Ahram Summer, 2017 Advantage This is a major mechanism for rapid and transient regulation of enzyme activity. A most common mechanism is enzyme phosphorylation

More information

Lecture 5: Drug targets (continued)

Lecture 5: Drug targets (continued) Lecture 5: Drug targets (continued) IIa. Enzymes as drug targets (HMG-CoA example) Many drugs are inhibitors of enzymes that catalyze biologically important reactions. The conversion of HMG-CoA to mevalonic

More information

Processing of RNA II Biochemistry 302. February 18, 2004 Bob Kelm

Processing of RNA II Biochemistry 302. February 18, 2004 Bob Kelm Processing of RNA II Biochemistry 302 February 18, 2004 Bob Kelm What s an intron? Transcribed sequence removed during the process of mrna maturation Discovered by P. Sharp and R. Roberts in late 1970s

More information

Signal-Transduction Cascades - 2. The Phosphoinositide Cascade

Signal-Transduction Cascades - 2. The Phosphoinositide Cascade Signal-Transduction Cascades - 2 The Phosphoinositide Cascade Calcium ion as a second messenger Tyrosine kinase and receptor dimerization scribd.com Faisal Khatib JU The Phosphoinositide Cascade Used by

More information

Insulin mrna to Protein Kit

Insulin mrna to Protein Kit Insulin mrna to Protein Kit A 3DMD Paper BioInformatics and Mini-Toober Folding Activity Student Handout www.3dmoleculardesigns.com Insulin mrna to Protein Kit Contents Becoming Familiar with the Data...

More information

PAPER No. : 16, Bioorganic and biophysical chemistry MODULE No. : 22, Mechanism of enzyme catalyst reaction (I) Chymotrypsin

PAPER No. : 16, Bioorganic and biophysical chemistry MODULE No. : 22, Mechanism of enzyme catalyst reaction (I) Chymotrypsin Subject Paper No and Title 16 Bio-organic and Biophysical Module No and Title 22 Mechanism of Enzyme Catalyzed reactions I Module Tag CHE_P16_M22 Chymotrypsin TABLE OF CONTENTS 1. Learning outcomes 2.

More information

Section 1 Proteins and Proteomics

Section 1 Proteins and Proteomics Section 1 Proteins and Proteomics Learning Objectives At the end of this assignment, you should be able to: 1. Draw the chemical structure of an amino acid and small peptide. 2. Describe the difference

More information

Processing of RNA II Biochemistry 302. February 13, 2006

Processing of RNA II Biochemistry 302. February 13, 2006 Processing of RNA II Biochemistry 302 February 13, 2006 Precursor mrna: introns and exons Intron: Transcribed RNA sequence removed from precursor RNA during the process of maturation (for class II genes:

More information

The Basics: A general review of molecular biology:

The Basics: A general review of molecular biology: The Basics: A general review of molecular biology: DNA Transcription RNA Translation Proteins DNA (deoxy-ribonucleic acid) is the genetic material It is an informational super polymer -think of it as the

More information

Lecture 3. Tandem MS & Protein Sequencing

Lecture 3. Tandem MS & Protein Sequencing Lecture 3 Tandem MS & Protein Sequencing Nancy Allbritton, M.D., Ph.D. Department of Physiology & Biophysics 824-9137 (office) nlallbri@uci.edu Office- Rm D349 Medical Science D Bldg. Tandem MS Steps:

More information

Regulation of cell function by intracellular signaling

Regulation of cell function by intracellular signaling Regulation of cell function by intracellular signaling Objectives: Regulation principle Allosteric and covalent mechanisms, Popular second messengers, Protein kinases, Kinase cascade and interaction. regulation

More information

Molecular Graphics Perspective of Protein Structure and Function

Molecular Graphics Perspective of Protein Structure and Function Molecular Graphics Perspective of Protein Structure and Function VMD Highlights > 20,000 registered Users Platforms: Unix (16 builds) Windows MacOS X Display of large biomolecules and simulation trajectories

More information

Chemistry 135, First Exam. September 23, Chem 135, Exam 1 SID:

Chemistry 135, First Exam. September 23, Chem 135, Exam 1 SID: Chemistry 135, First Exam September 23, 2015 This exam will be worth 15% of your overall grade. Please read all instructions/questions carefully and provide answers in the space provided. There should

More information

MOLECULAR CELL BIOLOGY

MOLECULAR CELL BIOLOGY 1 Lodish Berk Kaiser Krieger scott Bretscher Ploegh Matsudaira MOLECULAR CELL BIOLOGY SEVENTH EDITION CHAPTER 13 Moving Proteins into Membranes and Organelles Copyright 2013 by W. H. Freeman and Company

More information

Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system

Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system Basic Elements of cell signaling: Signal or signaling molecule (ligand, first messenger) o Small molecules (epinephrine,

More information

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds Uncatalyzed half-life Peptide hydrolysis uncatalyzed half-life = ~450 years IV protease-catalyzed half-life = ~3 seconds Life Sciences 1a Lecture Slides Set 9 Fall 2006-2007 Prof. David R. Liu In the absence

More information

RNA Processing in Eukaryotes *

RNA Processing in Eukaryotes * OpenStax-CNX module: m44532 1 RNA Processing in Eukaryotes * OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 3.0 By the end of this section, you

More information

Amino acids. Side chain. -Carbon atom. Carboxyl group. Amino group

Amino acids. Side chain. -Carbon atom. Carboxyl group. Amino group PROTEINS Amino acids Side chain -Carbon atom Amino group Carboxyl group Amino acids Primary structure Amino acid monomers Peptide bond Peptide bond Amino group Carboxyl group Peptide bond N-terminal (

More information

CELLS. Cells. Basic unit of life (except virus)

CELLS. Cells. Basic unit of life (except virus) Basic unit of life (except virus) CELLS Prokaryotic, w/o nucleus, bacteria Eukaryotic, w/ nucleus Various cell types specialized for particular function. Differentiation. Over 200 human cell types 56%

More information

1. to understand how proteins find their destination in prokaryotic and eukaryotic cells 2. to know how proteins are bio-recycled

1. to understand how proteins find their destination in prokaryotic and eukaryotic cells 2. to know how proteins are bio-recycled Protein Targeting Objectives 1. to understand how proteins find their destination in prokaryotic and eukaryotic cells 2. to know how proteins are bio-recycled As a protein is being synthesized, decisions

More information

REGULATION OF ENZYME ACTIVITY. Medical Biochemistry, Lecture 25

REGULATION OF ENZYME ACTIVITY. Medical Biochemistry, Lecture 25 REGULATION OF ENZYME ACTIVITY Medical Biochemistry, Lecture 25 Lecture 25, Outline General properties of enzyme regulation Regulation of enzyme concentrations Allosteric enzymes and feedback inhibition

More information

P450 CYCLE. All P450s follow the same catalytic cycle of;

P450 CYCLE. All P450s follow the same catalytic cycle of; P450 CYCLE All P450s follow the same catalytic cycle of; 1. Initial substrate binding 2. First electron reduction 3. Oxygen binding 4. Second electron transfer 5 and 6. Proton transfer/dioxygen cleavage

More information

Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia

Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia Molecular Medicine: Gleevec and Chronic Myelogenous Leukemia Dec 14 & 19, 2006 Prof. Erin Shea Prof. Dan Kahne Cancer, Kinases and Gleevec: 1. What is CML? a. Blood cell maturation b. Philadelphia Chromosome

More information

Life Science 1A Final Exam. January 19, 2006

Life Science 1A Final Exam. January 19, 2006 ame: TF: Section Time Life Science 1A Final Exam January 19, 2006 Please write legibly in the space provided below each question. You may not use calculators on this exam. We prefer that you use non-erasable

More information

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Name SS# This exam is worth a total of 100 points. The number of points each question is worth is shown in parentheses after the question number. Good

More information

Mechanisms of alternative splicing regulation

Mechanisms of alternative splicing regulation Mechanisms of alternative splicing regulation The number of mechanisms that are known to be involved in splicing regulation approximates the number of splicing decisions that have been analyzed in detail.

More information

Objective: You will be able to explain how the subcomponents of

Objective: You will be able to explain how the subcomponents of Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:

More information

Mutations and Disease Mutations in the Myosin Gene

Mutations and Disease Mutations in the Myosin Gene Biological Sciences Initiative HHMI Mutations and Disease Mutations in the Myosin Gene Goals Explore how mutations can lead to disease using the myosin gene as a model system. Explore how changes in the

More information

Biochemistry 2 Recita0on Amino Acid Metabolism

Biochemistry 2 Recita0on Amino Acid Metabolism Biochemistry 2 Recita0on Amino Acid Metabolism 04-20- 2015 Glutamine and Glutamate as key entry points for NH 4 + Amino acid catabolism Glutamine synthetase enables toxic NH 4 + to combine with glutamate

More information

Tala Saleh. Ahmad Attari. Mamoun Ahram

Tala Saleh. Ahmad Attari. Mamoun Ahram 23 Tala Saleh Ahmad Attari Minna Mushtaha Mamoun Ahram In the previous lecture, we discussed the mechanisms of regulating enzymes through inhibitors. Now, we will start this lecture by discussing regulation

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature19102 Supplementary Discussion Benzothiazepine Binding in Ca V Ab Diltiazem and other benzothiazepines inhibit Ca V 1.2 channels in a frequency-dependent manner consistent with pore block

More information

Chemistry 107 Exam 4 Study Guide

Chemistry 107 Exam 4 Study Guide Chemistry 107 Exam 4 Study Guide Chapter 10 10.1 Recognize that enzyme catalyze reactions by lowering activation energies. Know the definition of a catalyst. Differentiate between absolute, relative and

More information

CHAPTER 10: REGULATORY STRATEGIES. Traffic signals control the flow of traffic

CHAPTER 10: REGULATORY STRATEGIES. Traffic signals control the flow of traffic CHAPTER 10: REGULATORY STRATEGIES Traffic signals control the flow of traffic INTRODUCTION CHAPTER 10 The activity of enzymes must often be regulated so that they function at the proper time and place.

More information

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Homework Watch the Bozeman video called, Biological Molecules Objective:

More information

Eukaryotic mrna is covalently processed in three ways prior to export from the nucleus:

Eukaryotic mrna is covalently processed in three ways prior to export from the nucleus: RNA Processing Eukaryotic mrna is covalently processed in three ways prior to export from the nucleus: Transcripts are capped at their 5 end with a methylated guanosine nucleotide. Introns are removed

More information

Enzymes: The Catalysts of Life

Enzymes: The Catalysts of Life Chapter 6 Enzymes: The Catalysts of Life Lectures by Kathleen Fitzpatrick Simon Fraser University Activation Energy and the Metastable State Many thermodynamically feasible reactions in a cell that could

More information

Processing of RNA II Biochemistry 302. February 14, 2005 Bob Kelm

Processing of RNA II Biochemistry 302. February 14, 2005 Bob Kelm Processing of RNA II Biochemistry 302 February 14, 2005 Bob Kelm What s an intron? Transcribed sequence removed during the process of mrna maturation (non proteincoding sequence) Discovered by P. Sharp

More information

UNDERSTANDING THE ROLE OF ATP HYDROLYSIS IN THE SPLICEOSOME

UNDERSTANDING THE ROLE OF ATP HYDROLYSIS IN THE SPLICEOSOME UNDERSTANDING THE ROLE OF ATP HYDROLYSIS IN THE SPLICEOSOME RNA Splicing Lecture 2, Biological Regulatory Mechanisms, H. Madhani Dept. of Biochemistry and Biophysics MAJOR MESSAGES Eight essential ATPases

More information

Polyomaviridae. Spring

Polyomaviridae. Spring Polyomaviridae Spring 2002 331 Antibody Prevalence for BK & JC Viruses Spring 2002 332 Polyoma Viruses General characteristics Papovaviridae: PA - papilloma; PO - polyoma; VA - vacuolating agent a. 45nm

More information

Complexity DNA. Genome RNA. Transcriptome. Protein. Proteome. Metabolites. Metabolome

Complexity DNA. Genome RNA. Transcriptome. Protein. Proteome. Metabolites. Metabolome DNA Genome Complexity RNA Transcriptome Systems Biology Linking all the components of a cell in a quantitative and temporal manner Protein Proteome Metabolites Metabolome Where are the functional elements?

More information

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12. Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.5 % SDS-PAGE gel under reducing and non-reducing conditions.

More information

Protein Modeling Event

Protein Modeling Event Protein Modeling Event School Name: School Number: Team Member 1: Team Member 2: : Pre-Build Score: On-Site Build Score: Test Score: Tie Breaker: Total: Final Rank: Part I: Pre-Build (40% of total score)

More information

A Self-Propelled Biological Process Plk1-Dependent Product- Activated, Feed-Forward Mechanism

A Self-Propelled Biological Process Plk1-Dependent Product- Activated, Feed-Forward Mechanism A Self-Propelled Biological Process Plk1-Dependent Product- Activated, Feed-Forward Mechanism The Harvard community has made this article openly available. Please share how this access benefits you. Your

More information

MBB 694:407, 115:511. Please use BLOCK CAPITAL letters like this --- A, B, C, D, E. Not lowercase!

MBB 694:407, 115:511. Please use BLOCK CAPITAL letters like this --- A, B, C, D, E. Not lowercase! MBB 694:407, 115:511 First Test Severinov/Deis Tue. Sep. 30, 2003 Name Index number (not SSN) Row Letter Seat Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions

More information

Signal Transduction: G-Protein Coupled Receptors

Signal Transduction: G-Protein Coupled Receptors Signal Transduction: G-Protein Coupled Receptors Federle, M. (2017). Lectures 4-5: Signal Transduction parts 1&2: nuclear receptors and GPCRs. Lecture presented at PHAR 423 Lecture in UIC College of Pharmacy,

More information

Introduction to proteins and protein structure

Introduction to proteins and protein structure Introduction to proteins and protein structure The questions and answers below constitute an introduction to the fundamental principles of protein structure. They are all available at [link]. What are

More information

BIO 311C Spring Lecture 15 Friday 26 Feb. 1

BIO 311C Spring Lecture 15 Friday 26 Feb. 1 BIO 311C Spring 2010 Lecture 15 Friday 26 Feb. 1 Illustration of a Polypeptide amino acids peptide bonds Review Polypeptide (chain) See textbook, Fig 5.21, p. 82 for a more clear illustration Folding and

More information

KEY CONCEPT QUESTIONS IN SIGNAL TRANSDUCTION

KEY CONCEPT QUESTIONS IN SIGNAL TRANSDUCTION Signal Transduction - Part 2 Key Concepts - Receptor tyrosine kinases control cell metabolism and proliferation Growth factor signaling through Ras Mutated cell signaling genes in cancer cells are called

More information

Genetic information flows from mrna to protein through the process of translation

Genetic information flows from mrna to protein through the process of translation Genetic information flows from mrn to protein through the process of translation TYPES OF RN (RIBONUCLEIC CID) RN s job - protein synthesis (assembly of amino acids into proteins) Three main types: 1.

More information

Chapter 3. Protein Structure and Function

Chapter 3. Protein Structure and Function Chapter 3 Protein Structure and Function Broad functional classes So Proteins have structure and function... Fine! -Why do we care to know more???? Understanding functional architechture gives us POWER

More information

CS612 - Algorithms in Bioinformatics

CS612 - Algorithms in Bioinformatics Spring 2016 Protein Structure February 7, 2016 Introduction to Protein Structure A protein is a linear chain of organic molecular building blocks called amino acids. Introduction to Protein Structure Amine

More information

L I F E S C I E N C E S

L I F E S C I E N C E S 1a L I F E S C I E N C E S 5 -UUA AUA UUC GAA AGC UGC AUC GAA AAC UGU GAA UCA-3 5 -TTA ATA TTC GAA AGC TGC ATC GAA AAC TGT GAA TCA-3 3 -AAT TAT AAG CTT TCG ACG TAG CTT TTG ACA CTT AGT-5 NOVEMBER 2, 2006

More information

2013 W. H. Freeman and Company. 12 Signal Transduction

2013 W. H. Freeman and Company. 12 Signal Transduction 2013 W. H. Freeman and Company 12 Signal Transduction CHAPTER 12 Signal Transduction Key topics: General features of signal transduction Structure and function of G protein coupled receptors Structure

More information

Chapter 23 Enzymes 1

Chapter 23 Enzymes 1 Chapter 23 Enzymes 1 Enzymes Ribbon diagram of cytochrome c oxidase, the enzyme that directly uses oxygen during respiration. 2 Enzyme Catalysis Enzyme: A biological catalyst. With the exception of some

More information

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department

Genome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Genome of Hepatitis B Virus VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Proto Oncogen and Oncogen Oncogen Proteins that possess the ability to cause

More information

MCB*4010 Midterm Exam / Winter 2008

MCB*4010 Midterm Exam / Winter 2008 MCB*4010 Midterm Exam / Winter 2008 Name: ID: Instructions: Answer all 4 questions. The number of marks for each question indicates how many points you need to provide. Write your answers in point form,

More information

Name: Multiple choice questions. Pick the BEST answer (2 pts ea)

Name: Multiple choice questions. Pick the BEST answer (2 pts ea) Exam 1 202 Oct. 5, 1999 Multiple choice questions. Pick the BEST answer (2 pts ea) 1. The lipids of a red blood cell membrane are all a. phospholipids b. amphipathic c. glycolipids d. unsaturated 2. The

More information

Mechanism of splicing

Mechanism of splicing Outline of Splicing Mechanism of splicing Em visualization of precursor-spliced mrna in an R loop Kinetics of in vitro splicing Analysis of the splice lariat Lariat Branch Site Splice site sequence requirements

More information

Life History of A Drug

Life History of A Drug DRUG ACTION & PHARMACODYNAMIC M. Imad Damaj, Ph.D. Associate Professor Pharmacology and Toxicology Smith 652B, 828-1676, mdamaj@hsc.vcu.edu Life History of A Drug Non-Specific Mechanims Drug-Receptor Interaction

More information

Summary of Endomembrane-system

Summary of Endomembrane-system Summary of Endomembrane-system 1. Endomembrane System: The structural and functional relationship organelles including ER,Golgi complex, lysosome, endosomes, secretory vesicles. 2. Membrane-bound structures

More information

Short polymer. Dehydration removes a water molecule, forming a new bond. Longer polymer (a) Dehydration reaction in the synthesis of a polymer

Short polymer. Dehydration removes a water molecule, forming a new bond. Longer polymer (a) Dehydration reaction in the synthesis of a polymer HO 1 2 3 H HO H Short polymer Dehydration removes a water molecule, forming a new bond Unlinked monomer H 2 O HO 1 2 3 4 H Longer polymer (a) Dehydration reaction in the synthesis of a polymer HO 1 2 3

More information

REGULATED AND NONCANONICAL SPLICING

REGULATED AND NONCANONICAL SPLICING REGULATED AND NONCANONICAL SPLICING RNA Processing Lecture 3, Biological Regulatory Mechanisms, Hiten Madhani Dept. of Biochemistry and Biophysics MAJOR MESSAGES Splice site consensus sequences do have

More information

Lecture 15. Signal Transduction Pathways - Introduction

Lecture 15. Signal Transduction Pathways - Introduction Lecture 15 Signal Transduction Pathways - Introduction So far.. Regulation of mrna synthesis Regulation of rrna synthesis Regulation of trna & 5S rrna synthesis Regulation of gene expression by signals

More information

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor!

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor! Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor Allosteric pocket SHP2 Phosphatase ovel allosteric Phosphatase inhibitor Evan Carder Wipf

More information

Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression. Chromatin Array of nuc

Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression. Chromatin Array of nuc Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression Chromatin Array of nuc 1 Transcriptional control in Eukaryotes: Chromatin undergoes structural changes

More information

MCB Chapter 11. Topic E. Splicing mechanism Nuclear Transport Alternative control modes. Reading :

MCB Chapter 11. Topic E. Splicing mechanism Nuclear Transport Alternative control modes. Reading : MCB Chapter 11 Topic E Splicing mechanism Nuclear Transport Alternative control modes Reading : 419-449 Topic E Michal Linial 14 Jan 2004 1 Self-splicing group I introns were the first examples of catalytic

More information

Chemical Mechanism of Enzymes

Chemical Mechanism of Enzymes Chemical Mechanism of Enzymes Enzyme Engineering 5.2 Definition of the mechanism 1. The sequence from substrate(s) to product(s) : Reaction steps 2. The rates at which the complex are interconverted 3.

More information

Prediction and Statistical Analysis of Alternatively Spliced Exons

Prediction and Statistical Analysis of Alternatively Spliced Exons Prediction and Statistical Analysis of Alternatively Spliced Exons T.A. Thanaraj 1 and S. Stamm 2 The completion of large genomic sequencing projects revealed that metazoan organisms abundantly use alternative

More information

6.5 Enzymes. Enzyme Active Site and Substrate Specificity

6.5 Enzymes. Enzyme Active Site and Substrate Specificity 180 Chapter 6 Metabolism 6.5 Enzymes By the end of this section, you will be able to: Describe the role of enzymes in metabolic pathways Explain how enzymes function as molecular catalysts Discuss enzyme

More information

Figure mouse globin mrna PRECURSOR RNA hybridized to cloned gene (genomic). mouse globin MATURE mrna hybridized to cloned gene (genomic).

Figure mouse globin mrna PRECURSOR RNA hybridized to cloned gene (genomic). mouse globin MATURE mrna hybridized to cloned gene (genomic). Splicing Figure 14.3 mouse globin mrna PRECURSOR RNA hybridized to cloned gene (genomic). mouse globin MATURE mrna hybridized to cloned gene (genomic). mrna Splicing rrna and trna are also sometimes spliced;

More information

Bio 111 Study Guide Chapter 17 From Gene to Protein

Bio 111 Study Guide Chapter 17 From Gene to Protein Bio 111 Study Guide Chapter 17 From Gene to Protein BEFORE CLASS: Reading: Read the introduction on p. 333, skip the beginning of Concept 17.1 from p. 334 to the bottom of the first column on p. 336, and

More information

Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase. Biol 405 Molecular Medicine

Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase. Biol 405 Molecular Medicine Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase Biol 405 Molecular Medicine 1998 Crystal structure of phenylalanine hydroxylase solved. The polypeptide consists of three regions: Regulatory

More information

In Vivo Regulation of Alternative Pre-mRNA Splicing by the Clk1 Protein Kinase

In Vivo Regulation of Alternative Pre-mRNA Splicing by the Clk1 Protein Kinase MOLECULAR AND CELLULAR BIOLOGY, Oct. 1997, p. 5996 6001 Vol. 17, No. 10 0270-7306/97/$04.00 0 Copyright 1997, American Society for Microbiology In Vivo Regulation of Alternative Pre-mRNA Splicing by the

More information

Lecture 19: Review of regulation

Lecture 19: Review of regulation Chem*3560 Lecture 19: Review of regulation What is meant by cooperative allosteric regulation? Positive cooperativity - characteristic is the sigmoidal binding/activity curve T-state has weaker affinity,

More information

Intracellular Compartments and Protein Sorting

Intracellular Compartments and Protein Sorting Intracellular Compartments and Protein Sorting Intracellular Compartments A eukaryotic cell is elaborately subdivided into functionally distinct, membrane-enclosed compartments. Each compartment, or organelle,

More information